Search results for: Health Policy and Regulation
Filter search results
Interventions that Encourage High-value Nursing Home Care: Lessons for the UK
1 August 2017
This OHE Seminar Briefing summarises a seminar given by Professor David Grabowski, which provided a health economics perspective on how payment and delivery interventions can encourage high-value nursing home care….
Personalised Medicine: is it an Oil-Rush or Oil-Spill?
1 May 2020
…purpose, and raising some difficult issues with product pricing. This more tailored approach is producing important changes in drug development, regulation, and use. Mullard (2020; see Figure 1) suggests the…
Using Target Product Profiles (TPPs) to improve diagnostic testing for cancer
10 June 2024
…experts, research and innovation funders, innovators in research institutes and industry, regulators, health technology assessment expertise, policymakers and payers, and the patient voice. TPP development has two key stages: inception…
Exploring Local NHS Decisions about Investment
4 February 2011
…Health Economics at the University of York. For the coming few months, he will be based at OHE working with Professors Nancy Devlin (OHE’s Director of Research) and with David…
Valuing the National Clinical Assessment Service
1 April 2011
…review, semi-structured interviews with six senior NCAS staff members and with the medical, dental and pharmacy professions (BMA, BDA and RPS), and discussion groups with a total of 23 senior medical…
New: Antimicrobial Drug Incentives
6 April 2011
…and has begun to command attention from European and US policy makers. An initial focus on monitoring AMR and conserving existing treatments by cutting down on misuse has been complemented…
Effects of Public and Charitable Research Funding
20 April 2011
…UK fiscal deficit makes it likely that government funding of health and medical research will remain under scrutiny. This will include both return on investment, in economic and health status…
Drugs and Vaccines for Developing Countries
1 June 2011
…and initiatives, then, is essential to understanding which policies and programs work well and which do not. Towse, A., Keuffel, E., Kettler, H.E. and Ridley, D.B. Drugs and vaccines for developing…
Previews of Forthcoming Publications
27 July 2011
…of approaches can be identified. Towse, A., Keuffel, E., Kettler, H.E. and Ridley, D.B. (2011) Drugs and vaccines for developing countries. Occasional Paper. London: Office of Health Economics. In ‘Measuring…